Human Parainfluenza Virus Test Kits Market

The Human Parainfluenza Virus Test Kits Market is advancing rapidly, reflecting a shift in clinical priorities, technological innovation, and organizational requirements as healthcare providers respond to evolving respiratory diagnostic needs. Senior decision-makers are increasingly focusing on platforms that combine clinical accuracy with reliable workflow integration.

Market Snapshot: Human Parainfluenza Virus Test Kits Market

The Human Parainfluenza Virus Test Kits Market grew from USD 295.98 million in 2025 to USD 316.86 million in 2026. It is expected to continue growing at a CAGR of 7.03%, reaching USD 476.22 million by 2032. The primary keyword, Human Parainfluenza Virus Test Kits Market, is seeing continuous momentum as multisite health systems seek robust, end-to-end diagnostic capabilities in respiratory care.

Scope & Segmentation

Product Types: Molecular kits and antigen-based test kits, each with distinct advantages for analytical rigor or rapid deployment.
Testing Approaches: Standalone assays and multiplex respiratory panels, optimizing for either depth of information or workflow efficiency.
End Users: Hospitals and integrated networks, independent clinical laboratories, public health institutions, reference labs, and decentralized clinical environments.
Specimen Types: Nasopharyngeal swabs, nasal swabs, aspirates, and additional site-specific sample formats.
Distribution Channels: Direct sales for complex implementations; distributors supporting smaller sites and logistics management.
Platform Integration: Closed systems for standardization and reduced contamination; open systems for vendor flexibility and cost management.
Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific, each with individualized procurement drivers and infrastructure needs.
Technology Trends: Syndromic multiplexing, automation, cartridge-based workflows, high-throughput pipelines, and informatics integration for streamlined operations.

Key Takeaways

Clinical overlap among respiratory pathogens is driving laboratories toward confirmatory HPIV diagnostics to inform patient isolation, antimicrobial stewardship, and escalation protocols.
Adoption is influenced by end-user workflow fit, IT infrastructure, and the ability to integrate with respiratory panels, making operational compatibility essential for procurement decisions.
Technology shifts such as automation, syndromic multiplexing, and advanced sample-to-answer platforms are reshaping product design, performance validation, and procurement strategies.
Supply-chain resilience—covering everything from reagent stability to rapid restocking—now forms a core criterion in vendor evaluations, especially during seasonal or disruptive surges.
Quality expectations are rising, placing greater emphasis on design controls, performance transparency, and change management for both kits and supporting software.
Segmentation analysis shows workflow burden minimization and specimen compatibility are critical for market differentiation, with instrument ecosystem strategies affecting platform choices.

Tariff Impact on the HPIV Test Kits Market

Potential 2025 U.S. tariff changes may affect costs of plastics, reagents, consumables, and subcomponents within the diagnostics supply chain. Strategic responses may involve procurement contract adjustments, expanded bonded inventories, localized manufacturing, or network rebalancing to mitigate risk. Short-term procurement could be impacted by volatility in landed costs, contract negotiations focused on risk management, and shifts in supplier selection based on resilience and pricing structures.

Methodology & Data Sources

This report is grounded in a triangulated research strategy combining regulatory reviews, product documentation analysis, and structured stakeholder interviews throughout the diagnostics value chain. Data points were cross-verified through regulatory filings, product labeling, peer-reviewed studies, procurement records, and direct input from laboratory leaders, suppliers, and procurement professionals to ensure a practically relevant and unbiased narrative.

Why This Report Matters

Enables procurement and laboratory leaders to benchmark diagnostic strategies against evolving clinical, operational, and regulatory realities in respiratory care.
Assists product developers and suppliers in identifying priority segments, technology trends, and procurement expectations across critical global regions.
Supports executive teams in risk assessment, total cost analyses, and strategic planning for supply continuity amid tariff fluctuations and rising quality standards.

Conclusion

HPIV test kit market growth is underpinned by clinical demand for rapid, reliable respiratory diagnostics, supply resilience, and workflow-aligned solutions. Strategic decisions will remain pivotal as operational, technological, and regulatory demands evolve.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Human Parainfluenza Virus Test Kits Market, by Product

8.1. Isothermal Kits
8.2. Rapid Test Kits
8.3. Real Time Pcr Kits

9. Human Parainfluenza Virus Test Kits Market, by Technology

9.1. Immunoassay
9.1.1. Chemiluminescence Immunoassay
9.1.2. Enzyme Linked Immunosorbent Assay
9.1.3. Lateral Flow Immunoassay
9.2. Molecular
9.2.1. Isothermal Amplification
9.2.2. Next Generation Sequencing
9.2.3. Real Time Pcr

10. Human Parainfluenza Virus Test Kits Market, by End User

10.1. Academic And Research Institutes
10.2. Diagnostic Laboratories
10.3. Hospitals
10.4. Point Of Care Centers

11. Human Parainfluenza Virus Test Kits Market, by Sample Type

11.1. Nasopharyngeal Swab
11.2. Oropharyngeal Swab
11.3. Sputum

12. Human Parainfluenza Virus Test Kits Market, by Application

12.1. Clinical Diagnosis
12.2. Epidemiological Surveillance
12.3. Research

13. Human Parainfluenza Virus Test Kits Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Human Parainfluenza Virus Test Kits Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Human Parainfluenza Virus Test Kits Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Human Parainfluenza Virus Test Kits Market
17. China Human Parainfluenza Virus Test Kits Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. Anatolia Tani ve Biyoteknoloji Urunleri Sanayi ve Ticaret A.S.
18.7. Becton, Dickinson and Company
18.8. Beijing OriginGene-Tech Biotechnology Co.,Ltd
18.9. BioFire Diagnostics
18.10. bioMérieux SA
18.11. Certest Biotec
18.12. Cortez Diagnostics
18.13. Daan Gene Co., Ltd.
18.14. DBLue Medical
18.15. Genematrix Inc.
18.16. GenMark Diagnostics, Inc.
18.17. Hologic Inc.
18.18. Huwel Lifesciences
18.19. Luminex Corporation
18.20. QIAGEN N.V.
18.21. QuidelOrtho
18.22. R-Biopharm AG
18.23. Roche Holding AG
18.24. Seegene
18.25. Thermo Fisher Scientific
18.26. Xian Tianlong Science and Technology
18.27. Zhejiang Orient Gene

List of Figures

FIGURE 1. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RAPID TEST KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RAPID TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RAPID TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY POINT OF CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY POINT OF CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY POINT OF CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SPUTUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SPUTUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SPUTUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY CLINICAL DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY EPIDEMIOLOGICAL SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. EUROPE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 107. EUROPE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 108. EUROPE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 109. EUROPE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 110. EUROPE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. EUROPE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 112. EUROPE HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 113. MIDDLE EAST HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. MIDDLE EAST HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 115. MIDDLE EAST HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 122. AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 123. AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 124. AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 125. AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 126. AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 127. AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 128. AFRICA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 129. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 131. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 133. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. ASEAN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. ASEAN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 140. ASEAN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 141. ASEAN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 142. ASEAN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 143. ASEAN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. ASEAN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASEAN HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. GCC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GCC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 148. GCC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. GCC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 150. GCC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 151. GCC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. GCC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 153. GCC HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPEAN UNION HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 162. BRICS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. BRICS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 164. BRICS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 165. BRICS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 166. BRICS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 167. BRICS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. BRICS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 169. BRICS HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. G7 HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. G7 HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 172. G7 HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 173. G7 HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 174. G7 HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 175. G7 HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. G7 HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 177. G7 HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. NATO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. NATO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 180. NATO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. NATO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 182. NATO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 183. NATO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. NATO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 185. NATO HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 188. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 189. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 190. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 191. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 192. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 194. UNITED STATES HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 196. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 197. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY IMMUNOASSAY, 2018-2032 (USD MILLION)
TABLE 199. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY MOLECULAR, 2018-2032 (USD MILLION)
TABLE 200. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 201. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 202. CHINA HUMAN PARAINFLUENZA VIRUS TEST KITS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Human Parainfluenza Virus Test Kits market report include:

Abbott Laboratories
Anatolia Tani ve Biyoteknoloji Urunleri Sanayi ve Ticaret A.S.
Becton, Dickinson and Company
Beijing OriginGene-Tech Biotechnology Co.,Ltd
BioFire Diagnostics
bioMérieux SA
Certest Biotec
Cortez Diagnostics
Daan Gene Co., Ltd.
DBLue Medical
Genematrix Inc.
GenMark Diagnostics, Inc.
Hologic Inc.
Huwel Lifesciences
Luminex Corporation
QIAGEN N.V.
QuidelOrtho
R-Biopharm AG
Roche Holding AG
Seegene
Thermo Fisher Scientific
Xian Tianlong Science and Technology
Zhejiang Orient Gene

Table Information

Report Attribute	Details
No. of Pages	181
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 316.86 Million
Forecasted Market Value ( USD ) by 2032	$ 476.22 Million
Compound Annual Growth Rate	7.0%
Regions Covered	Global
No. of Companies Mentioned	24

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3423EUR$3,939USD£2,984GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3692EUR$4,249USD£3,219GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5004EUR$5,759USD£4,363GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6056EUR$6,969USD£5,279GBP

Human Parainfluenza Virus Test Kits Market - Global Forecast 2026-2032

Market Snapshot: Human Parainfluenza Virus Test Kits Market

Scope & Segmentation

Key Takeaways